4.0
13 June 2026
Current employee, more than 5 years
Recommend
CEO approval
Business outlook
Pros
Flexibility in terms of going to the office, good healthcare benefits
Cons
Lower pay than most pharma companies, a lot of changes and lately a lot of uncertainty